DK351886A - 4-oh-quinolincarboxylsyrederivater, deres fremstilling, mellemprodukter ved deres fremstilling samt laegemidler med indhold deraf - Google Patents

4-oh-quinolincarboxylsyrederivater, deres fremstilling, mellemprodukter ved deres fremstilling samt laegemidler med indhold deraf Download PDF

Info

Publication number
DK351886A
DK351886A DK351886A DK351886A DK351886A DK 351886 A DK351886 A DK 351886A DK 351886 A DK351886 A DK 351886A DK 351886 A DK351886 A DK 351886A DK 351886 A DK351886 A DK 351886A
Authority
DK
Denmark
Prior art keywords
preparation
alkyl
intermediates
contents
acid derivatives
Prior art date
Application number
DK351886A
Other languages
English (en)
Other versions
DK172034B1 (da
DK351886D0 (da
Inventor
Francois Clemence
Odile Le Martret
Francoise Delevallee
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DK351886D0 publication Critical patent/DK351886D0/da
Publication of DK351886A publication Critical patent/DK351886A/da
Application granted granted Critical
Publication of DK172034B1 publication Critical patent/DK172034B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK351886A 1985-07-25 1986-07-24 4-OH-quinolincarboxylsyrederivater, deres fremstilling, mellemprodukter ved deres fremstilling samt lægemidler med indhold deraf DK172034B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8511389 1985-07-25
FR8511389A FR2585356B1 (fr) 1985-07-25 1985-07-25 Nouveaux derives de l'acide 4-oh quinoleine carboxylique substitues en 2 par deux fonctions hydroxyle eventuellement etherifiees ou esterifiees, leurs procedes de preparation, les nouveaux intermediaires obtenus, leur application comme medicaments et les compositions les renfermant

Publications (3)

Publication Number Publication Date
DK351886D0 DK351886D0 (da) 1986-07-24
DK351886A true DK351886A (da) 1987-01-26
DK172034B1 DK172034B1 (da) 1997-09-22

Family

ID=9321642

Family Applications (1)

Application Number Title Priority Date Filing Date
DK351886A DK172034B1 (da) 1985-07-25 1986-07-24 4-OH-quinolincarboxylsyrederivater, deres fremstilling, mellemprodukter ved deres fremstilling samt lægemidler med indhold deraf

Country Status (16)

Country Link
EP (1) EP0214004B1 (da)
JP (1) JPH0710863B2 (da)
KR (1) KR940003759B1 (da)
AT (1) ATE87625T1 (da)
AU (1) AU609377B2 (da)
CA (1) CA1262903A (da)
DE (1) DE3688161T2 (da)
DK (1) DK172034B1 (da)
ES (1) ES2000739A6 (da)
FI (1) FI86426C (da)
FR (1) FR2585356B1 (da)
GR (1) GR861924B (da)
HU (1) HU202526B (da)
PT (1) PT83064B (da)
SU (1) SU1584749A3 (da)
ZA (1) ZA865260B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845105A (en) * 1984-10-30 1989-07-04 Roussel Uclaf 4-OH-quinoline carboxylic acid amides having analgesic and anti-inflammatory activity
US5438344A (en) * 1990-11-05 1995-08-01 Oliva; Anthony Portable video book
GB9108547D0 (en) * 1991-04-22 1991-06-05 Fujisawa Pharmaceutical Co Quinoline derivatives
WO1997048707A1 (en) * 1996-06-20 1997-12-24 Smithkline Beecham Plc 4h-3,1-benzoxazin-4-one derivatives and analogs as antiviral agents
JP3337992B2 (ja) * 1997-11-04 2002-10-28 ファイザー製薬株式会社 5−置換ピコリン酸化合物及びその製造方法
JP4804590B1 (ja) 2010-04-14 2011-11-02 帝人テクノプロダクツ株式会社 メタ型全芳香族ポリアミド繊維

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2509728A1 (fr) * 1981-07-17 1983-01-21 Roussel Uclaf Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
FR2530633A1 (fr) * 1982-06-03 1984-01-27 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, et les compositions les renfermant
FR2566405B1 (fr) * 1984-06-25 1986-09-26 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
ZA871658B (en) * 1986-03-27 1987-08-28 Warner-Lambert Company Chewing gum and confectionery compositions containing a soy flavor enhancer

Also Published As

Publication number Publication date
AU609377B2 (en) 1991-05-02
KR940003759B1 (ko) 1994-04-30
GR861924B (en) 1986-11-25
EP0214004A3 (en) 1989-04-05
SU1584749A3 (ru) 1990-08-07
FI863040A7 (fi) 1987-01-26
PT83064B (pt) 1989-02-28
AU6050986A (en) 1987-01-29
EP0214004B1 (fr) 1993-03-31
HUT43598A (en) 1987-11-30
KR870001206A (ko) 1987-03-12
CA1262903A (fr) 1989-11-14
FI863040A0 (fi) 1986-07-24
DK172034B1 (da) 1997-09-22
FI86426C (fi) 1992-08-25
FR2585356A1 (fr) 1987-01-30
JPH0710863B2 (ja) 1995-02-08
EP0214004A2 (fr) 1987-03-11
DK351886D0 (da) 1986-07-24
DE3688161T2 (de) 1993-10-14
DE3688161D1 (de) 1993-05-06
ATE87625T1 (de) 1993-04-15
PT83064A (en) 1986-08-01
FI86426B (fi) 1992-05-15
ZA865260B (en) 1987-09-30
HU202526B (en) 1991-03-28
FR2585356B1 (fr) 1987-10-23
ES2000739A6 (es) 1988-03-16
JPS6229585A (ja) 1987-02-07

Similar Documents

Publication Publication Date Title
FI820281L (fi) Foerfarande foer framstaellning av 2-penemkompositioner med forfarandet framstaellda nya 2-penemkompositioner och dessa inehaollande farmaceutiska blandningar
FI860369A0 (fi) Imidazolderivat, deras framstaellning och anvaendning samt dessa derivat innehaollande farmaceutiska kompositioner.
DK288287D0 (da) Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande
DK351886D0 (da) 4-oh-quinolincarboxylsyrederivater, deres fremstilling, mellemprodukter ved deres fremstilling samt laegemidler med indhold deraf
AR241136A2 (es) Procedimiento para preparar esteres de 6-hidroxi-2-benzotiazolsulfonamida para tratamiento topicode presion intraocular elevada"
DK327286A (da) Indolcarboxamidderivater og salte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter til deres fremstilling
FI951297A0 (fi) Uuudet aminoalkyyli-bentsoksatsolinonit ja -bentsotiatsolinonit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
BR8600715A (pt) Processo para a preparacao de 1,3-tiazol-2-iloxiacetamidas 4,5-dissubstituidas,composicao herbicida,aplicacao e processo para a preparacao de composicoes
DE68923320D1 (de) Derivate von Aminsäuren.
DK176085D0 (da) 4-(nitrophenyl)-tetrahydropyridiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
FI830152L (fi) Diazolylalkanoler, foerfarande foer deras framstaellning och deras anvaendning saosom antimykotiskamedel
DK0485204T3 (da) Fremgangsmåde til fremstilling af 3-alkoxymethyl-cephalosporin-derivater
PH25225A (en) Process for preparing isothiazolones
FI102280B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-formyylibentsyylifosfonihappojohdannaisten valmistamiseksi
FI823732A0 (fi) Nya 1-furyl-3,4-dihydroisokinoliner, laekemedel innehaollande dessa samt deras framstaellningsfoerfaranden och deras anvaendning
DK280883A (da) Organophosphat-derivater, fremgangsmaade til fremstilling deraf samt deres anvendelse som midler til bekaempelse af skadelige organismer
FI850116L (fi) Aminoetyl-imidazol, farmaceutisk produkt innehaollande detta samt dess framstaellningsfoerfarande.
FI852710A0 (fi) Fenyletylaminopropiofenon-derivat, foerfaranden foer deras framstaellning och dessa innehaollande laekemedel.
FI833971A0 (fi) Nya semikarbazider, deras framstaellning och anvaendning
ES8304546A1 (es) Un procedimiento de preparacion de zomepirac y sus analogos.
GB2003874A (en) Diarylbutylpiperazines

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK